Doj Leniency Program: How Corporate Leniency Works and When to Apply

The program covers qualifying criminal conspiracies under Sections 1 and 3(a) of the Sherman Act, including price fixing, bid rigging, and market and customer allocation. The Antitrust Criminal Penalty Enhancement and Reform Act (ACPERA, 2004) extended the program's reach to civil litigation by limiting a qualifying applicant's civil damages exposure, conditioned on cooperation with civil plaintiffs. DOJ applies the policies and model conditional leniency letters in effect at the time the marker is issued.

Only the first qualifying organization or individual to report a criminal antitrust conspiracy is eligible for leniency for that conduct. A second applicant reporting the same conspiracy may cooperate as a witness but does not receive immunity. The eligibility conditions for Type A leniency close once DOJ has received information from another source. Companies and executives who delay while conducting internal assessments risk finding that a co-conspirator has already secured the first-in position.

Price fixing, bid rigging, and horizontal market and customer allocation agreements are the core qualifying offenses. DOJ proceeds on the fact of the illegal agreement itself rather than on evidence of competitive harm. Civil Section 1 claims, Section 2 monopolization and attempted monopolization, and conduct DOJ has not characterized as criminal are outside the program's scope.

An applicant must not have coerced any other participant and must clearly not have been the leader or originator of the cartel. These are separate requirements: coercion disqualifies without a leadership role, and clear leadership or originator status may disqualify without coercion. Size, market share, or extending the first invitation does not alone establish leadership; DOJ evaluates the applicant's relative role and culpability in light of all circumstances.

Type A requires that DOJ has not yet received information about the conduct from any source and has not opened an investigation directed at the applicant. The company must report promptly after discovery, provide complete and truthful information, cooperate from that point forward, undertake remediation including compliance improvements, and make restitution where possible. DOJ evaluates whether reporting was prompt in light of the time taken for an initial assessment and to engage counsel.

Type B applies when DOJ has already received information about the conduct but does not yet have evidence sufficient for a sustainable conviction against the applicant. Immunity is not automatic; DOJ assesses whether granting it serves the interests of justice given what the Division already knows and how much the applicant's cooperation adds. Protection for current personnel is also not guaranteed and is assessed individually. The earlier a Type B application is filed, the more likely cooperation will carry sufficient weight.

Under Type A, current directors, officers, and employees who provide timely, truthful, continuing, and complete cooperation receive protection from prosecution for the covered conduct. Under Type B, that protection for current personnel is not automatic; DOJ determines coverage case by case. Former employees are presumptively excluded under both types and may be included only when their cooperation is substantial and noncumulative, or when their participation is necessary to establish the corporate confession.

The agreement covers the specific conspiracy described in the application. Conduct outside that scope, other conspiracies not disclosed to DOJ, individual conduct beyond what was reported, and any false or incomplete statements made during cooperation remain exposed. An executive whose individual conduct extends beyond the disclosed conspiracy, or who is not among the current personnel covered under a Type B agreement, retains independent criminal risk the corporate agreement does not address.

A marker is obtained by contacting the Antitrust Division and providing the client's identity, the general nature of the conduct, and the industry, product, or service involved. The marker holds first-in position for an agreed period during which the company investigates and prepares its cooperation. It must be perfected within that period by providing the required full information; an unperfected marker may expire, allowing another applicant to take the first-in position. Multiple markers for different industries or conspiracies may be held simultaneously.

Once the marker is perfected, DOJ may issue a conditional leniency letter setting out ongoing obligations: truthful and complete cooperation, production of responsive nonprivileged information, best efforts to secure cooperation of covered current personnel, remediation, compliance improvements, and restitution where possible. Former personnel are not automatically within the company's control or the covered population and require separate treatment. The final leniency letter is issued after DOJ determines the applicant has satisfied all conditions and verified eligibility.

An individual cannot rely on the corporate agreement if the company proceeds under Type B (where individual coverage is not automatic), if the individual has exposure outside the covered conspiracy, or if the company's cooperation may exclude that individual. An executive who has reason to doubt whether the company will apply promptly, or whether their specific conduct will be included, should evaluate independent application before DOJ receives information from another source.

Leniency Plus applies when a company under investigation for one conspiracy self-reports a separate, unreported conspiracy: the company receives leniency for the second matter and a sentencing discount on the first. The corresponding risk is Penalty Plus. If DOJ later uncovers an additional antitrust crime the company failed to disclose, the Division may seek a more severe sentence for that second offense, including a higher fine, probation, or other aggravating consequences depending on the company's reasons for failing to investigate or report. Any company under active antitrust scrutiny has reason to assess whether unreported conduct exists.

Without ACPERA, a defendant found liable in a civil antitrust case faces treble damages and joint and several liability for the full conspiracy. A qualifying applicant's damages are limited to the portion of the claimant's actual damages attributable to commerce conducted by the applicant in the affected goods or services. That limitation removes both the treble damages multiplier and joint and several exposure for the conduct of co-conspirators.

ACPERA benefits depend on a court finding that the applicant provided satisfactory and timely cooperation to civil claimants. The statutory obligations include providing a full account of potentially relevant facts, producing relevant documents, and cooperating in interviews, depositions, and testimony of covered individuals. These obligations run alongside, but are legally distinct from, the applicant's duties to DOJ; the court overseeing the civil litigation makes the final determination of whether cooperation was satisfactory.